Provided are indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which LRRK2 kinase is involved. Also provided are pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK2 kinase is involved.
提供的是
吲唑烷类化合物,它们是LRRK2激酶的强效
抑制剂,可用于治疗或预防LRRK2激酶参与的疾病。还提供了包含这些化合物的药物组合物,以及这些化合物和组合物在预防或治疗LRRK2激酶参与的疾病中的用途。